NDC 63323-400-01 - Levetiracetam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-400
- Requested NDC
- 63323-400-01
- Package NDCs from labels
- 63323-400-41, 63323-400-44, 63323-400-01, 63323-400-05
- Manufacturer
- Fresenius Kabi USA, LLC
- Effective date
- 2022-02-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levetiracetam - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2022-02-28 | HUMAN PRESCRIPTION DRUG LABEL |
| Levetiracetam - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2022-01-24 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-400-41 | Levetiracetam | 5 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION | 5 | 7 | |
| 63323-400-44 | Levetiracetam | 10 in 1 TRAY | INJECTION, SOLUTION | 10 | 7 | |
| 63323-400-01 | Levetiracetam | 5 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION | 5 | 6 | |
| 63323-400-05 | Levetiracetam | 10 in 1 TRAY | INJECTION, SOLUTION | 10 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-400 | LEVETIRACETAM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ] | 7 | Current NDC, Legacy NDC, 2 package rows | 20220323_cc4a06f1-6509-4650-b20c-259a39353733.zip |
| 63323-400 | LEVETIRACETAM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 6 | Current NDC, Legacy NDC, 2 package rows | 20220222_cc41696c-9cf0-4410-bacc-09132ee805ce.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-400-01 | ML - Milliliter | 63323-400 | cbb8ceee-dd53-43c2-9499-b805bdf960f7 | 1 | 2023-09-05 |
| 63323-400-05 | ML - Milliliter | 63323-400 | 239be9d6-dfd7-4306-87fb-c0753bd4b55f | 1 | 2015-12-02 |
| 63323-400-09 | ML - Milliliter | 63323-400 | 6a3eead4-fa02-45c6-a9d4-dc0d8bb27acd | 1 | 2013-08-02 |
| 63323-400-41 | ML - Milliliter | 63323-400 | c3810bb2-5abe-4c4a-a784-ba543e1de2d5 | 1 | 2019-06-19 |
| 63323-400-44 | ML - Milliliter | 63323-400 | e3a18f89-b046-48aa-88da-10ca5765786c | 1 | 2019-06-19 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LEVETIRACETAM | ACTIVE INGREDIENT | 44YRR34555 | LEVETIRACETAM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | |
| LEVETIRACETAM | ACTIVE MOIETY | 44YRR34555 | LEVETIRACETAM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | |
| ACETIC ACID | INACTIVE INGREDIENT | Q40Q9N063P | LEVETIRACETAM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | |
| SODIUM ACETATE | INACTIVE INGREDIENT | 4550K0SC9B | LEVETIRACETAM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | LEVETIRACETAM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | LEVETIRACETAM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levetiracetam | LEVETIRACETAM | REMEDYREPACK INC. | a1b28234-1f7c-40bf-80a7-6cc98b3839fe | 2026-08-05 | Warnings, Adverse reactions | 44YRR34555 |
| Anpitua Stim | ADRENOCORTICOTROPHIN, AGNUS CASTUS, BARYTA CARBONICA, CALCAREA CARBONICA, IODIUM, LAC CANINUM, NATRUM MURIATICUM, PHOSPHORICUM ACIDUM, SEPIA, THYROIDINUM SUIS, | J and Health DBA Wise Alternative | c96d09bc-eaf7-4977-8f22-68246839f37d | 2026-08-05 | Warnings | 451W47IQ8X |
| LEVETIRACETAM | LEVETIRACETAM | Micro Labs Limited | 1e3cfafe-5784-4ec6-91dc-cd74b01d0bb4 | 2026-08-03 | Warnings, Adverse reactions | 647121 44YRR34555 |
| Metabatone | ARALIA RACEMOSA, AVENA SATIVA, BERBERIS VULGARIS, CAPSICUM ANNUUM, GINKGO BILOBA, PHYTOLACCA DECANDRA, HYPOTHALAMUS SUIS, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-KETOGLUTARICUM ACIDUM, FEL TAURI, HYALURONIDASE, PANCREAS SUIS, PANCREATINUM, PAPAIN, STOMACH (SUIS), L-ALANINE, L- ARGININE, L-CARNITINE, CYSTEINUM, L-GLUTAMINE, L-HISTIDINE, L-ISOLEUCINE, L-LEUCINE, L-LYSINE, L-METHIONINE, L-ORNITHINE, L-PROLINE, L-SERINE, L-TRYPTOPHAN, L-TYROSINE, L-VALINE, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, IODIUM, | Energique, Inc. | 9510bb76-b717-407d-b9e8-da7743e4cfc8 | 2026-07-31 | Warnings | 451W47IQ8X |
| Garzulys | INSULIN ASPART-FSAN | Meitheal Pharmaceuticals Inc. | 30c64769-d2f7-4604-ac9e-2a6bc09506c9 | 2026-07-31 | Warnings, Adverse reactions | 059QF0KO0R |
| Bioplasma | SILICON DIOXIDE,POTASSIUM CHLORIDE,SODIUM SULFATE,FERROSOFERRIC PHOSPHATE,MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE,SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE,TRIBASIC CALCIUM PHOSPHATE,POTASSIUM PHOSPHATE, DIBASIC,POTASSIUM SULFATE,SODIUM CHLORIDE,CALCIUM SULFATE ANHYDROUS,CALCIUM FLUORIDE | Hyland's Inc. | dd0a7ed2-d112-4b96-e053-2995a90ac6b6 | 2026-07-30 | Warnings | 451W47IQ8X |
| Hypertonic Saline | SODIUM CHLORIDE | NAVEH PHARMA (1996) LTD | 167c7a9c-1228-4fb2-a89c-d3e148386323 | 2026-07-30 | Warnings | 451W47IQ8X |
| Hypertonic Saline Solution Sodium Chloride | SODIUM CHLORIDE | NAVEH PHARMA (1996) LTD | 750ea4b1-de2b-4299-aaa2-331daf383d0d | 2026-07-30 | Warnings | 451W47IQ8X |
| DECONIMO Reconstitution | DECONIMO RECONSTITUTION | Image Amazon LLC | 57ab9b1c-9a18-3786-e063-6394a90a2c63 | 2026-07-28 | Warnings | 059QF0KO0R |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | bbc5b820-4973-11e2-a192-0002a5d5c51b | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | c29bdfa0-4976-11e2-939b-0002a5d5c51b | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Delflex | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care de Mexico, S.A. de C.V. | a98facd6-9daa-4d37-8209-63a0599dbfaa | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | 515dcee0-3e34-11e2-a25f-0800200c9a66 | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Medical Care de Mexico, S.A. de C.V. | 9a1220fb-6853-45ae-838c-10d8596e1af7 | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | af5cdf1a-19f4-11e2-892e-0800200c9a66 | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Levetiracetam Levetiracetam | LEVETIRACETAM | Atlantic Biologicals Corp. | 56fed03f-38c3-4273-8fd7-522bc508bf36 | 2026-07-27 | Warnings, Adverse reactions | 44YRR34555 |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | A-S Medication Solutions | 19daf830-7270-4661-81b1-ded38f867f28 | 2026-07-24 | Warnings, Adverse reactions | 451W47IQ8X |
| Sterile Water | WATER | Cardinal Health 107, LLC | 9655cd02-82b5-4a75-813b-854b19551481 | 2026-07-21 | Warnings, Adverse reactions | 059QF0KO0R |
| Levetiracetam | LEVETIRACETAM | Cardinal Health 107, LLC | a91defd2-486b-4995-ba4c-640525ab575d | 2026-07-21 | Warnings, Adverse reactions | 44YRR34555 |
| Whisidom Saline Solution | SODIUM CHLORIDE 0.9% SALINE SOLUTION | Jiangxi Yudexi Pharmaceutical Co., LTD | 4e4e4169-2a14-3466-e063-6394a90a081b | 2026-07-20 | Warnings | 451W47IQ8X |